Publications by authors named "Mary-Kate Morris"

Claim this Profile
D
Development of ACE2-tropic-betacoronavirus therapeutics for future pandemic preparedness.
Ashley Utz, Matt Armbrust, Thuy-Tien T Nguyen, Mary Kate Morris, Chris O Matthews

Nat Commun· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential immunity induced by Omicron sublineages in naïve and vaccine breakthrough infections.
Noah Brazer, Mary Kate Morris, Venice Servellita, Miriam Oseguera, Nanami Sumimoto

Sci Rep· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccine-Boosted CCP Decreases Virus Replication and Hastens Resolution of Infection Despite Transiently Enhancing Disease in SARS-CoV-2-Infected Hamsters.
Timothy D Carroll, Talia Wong, Mary Kate Morris, Clara Di Germanio, Zhong-Min Ma

J Infect Dis· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates.
Payton A-B Weidenbacher, Mrinmoy Sanyal, Natalia Friedland, Shaogeng Tang, Prabhu S Arunachalam, Mary Kate Morris

Nat Commun· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Administration of vaccine-boosted COVID-19 convalescent plasma to SARS-CoV-2 infected hamsters decreases virus replication in lungs and hastens resolution of the infection despite transiently enhancing disease and lung pathology.
Timothy D Carroll, Talia Wong, Mary Kate Morris, Clara Di Germanio, Zhong-Min Ma

bioRxiv· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decreased efficacy of a COVID-19 vaccine due to mutations present in early SARS-CoV-2 variants of concern.
Payton A-B Weidenbacher, Natalia Friedland, Mrinmoy Sanyal, Mary Kate Morris, Jonathan Do

bioRxiv· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates.
Payton A-B Weidenbacher, Mrinmoy Sanyal, Natalia Friedland, Shaogeng Tang, Prabhu S Arunachalam, Mary Kate Morris

Nat Commun· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sylvatic Transmission of Chikungunya Virus among Nonhuman Primates in Myanmar.
Tierra Smiley Evans, Ohnmar Aung, Olivia Cords, Lark L Coffey, Talia Wong, Mary Kate Morris

Emerg Infect Dis· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates.
Payton A-B Weidenbacher, Mrinmoy Sanyal, Natalia Friedland, Shaogeng Tang, Prabhu S Arunachalam, Mary Kate Morris

bioRxiv· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Converting non-neutralizing SARS-CoV-2 antibodies into broad-spectrum inhibitors.
Payton A-B Weidenbacher, Eric Waltari, Izumi de Los Rios Kobara, Benjamin N Bell, Mary Kate Morris

Nat Chem Biol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutralizing Immunity Induced Against the Omicron BA.1 and BA.2 Variants in Vaccine Breakthrough Infections.
Noah Brazer, Mary Kate Morris, Venice Servellita, Khamal Anglin, Prachi Saldhi

J Infect Dis· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination.
Rahul K Suryawanshi, Irene P Chen, Tongcui Ma, Abdullah M Syed, Noah Brazer, Mary Kate Morris

Nature· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of neutralizing antibodies against multiple SARS-CoV-2 strains in dried blood spots using cell-free PCR.
Kenneth Danh, Donna Grace Karp, Malvika Singhal, Akshaya Tankasala, David Gebhart, Mary Kate Morris

Nat Commun· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multitope SARS-CoV-2 vaccine provides long-lasting B cell and T cell immunity against Delta and Omicron variants.
Chang Yi Wang, Kao-Pin Hwang, Hui-Kai Kuo, Wen-Jiun Peng, Yea-Huei Shen, Mary Kate Morris

J Clin Invest· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutralizing immunity in vaccine breakthrough infections from the SARS-CoV-2 Omicron and Delta variants.
Venice Servellita, Abdullah M Syed, Mary Kate Morris, Noah Brazer, Prachi Saldhi

Cell· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California.
Venice Servellita, Mary Kate Morris, Alicia Sotomayor-Gonzalez, Amelia S Gliwa, Erika Torres

Nat Microbiol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The B.1.427/1.429 (epsilon) SARS-CoV-2 variants are more virulent than ancestral B.1 (614G) in Syrian hamsters.
Timothy Carroll, Douglas Fox, Neeltje van Doremalen, Erin Ball, Mary Kate Morris

PLoS Pathog· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of Abbott BinaxNOW Rapid Antigen Test for Detection of SARS-CoV-2 Infections in Outbreak among Horse Racetrack Workers, California, USA.
Krishna Surasi, Kristin J Cummings, Carl Hanson, Mary Kate Morris, Maria Salas

Emerg Infect Dis· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The B.1.427/1.429 (epsilon) SARS-CoV-2 variants are more virulent than ancestral B.1 (614G) in Syrian hamsters.
Timothy Carroll, Douglas Fox, Neeltje van Doremalen, Erin Ball, Mary Kate Morris

bioRxiv· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant.
Xianding Deng, Miguel A Garcia-Knight, Mir M Khalid, Venice Servellita, Candace Wang, Mary Kate Morris

Cell· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transmission, infectivity, and antibody neutralization of an emerging SARS-CoV-2 variant in California carrying a L452R spike protein mutation.
Xianding Deng, Miguel A Garcia-Knight, Mir M Khalid, Venice Servellita, Candace Wang, Mary Kate Morris

medRxiv· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineering of a Lectibody Targeting High-Mannose-Type Glycans of the HIV Envelope.
Krystal Teasley Hamorsky, J Calvin Kouokam, Matthew W Dent, Tiffany N Grooms, Adam S Husk, Mary Kate Morris

Mol Ther· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deficient synthesis of class-switched, HIV-neutralizing antibodies to the CD4 binding site and correction by electrophilic gp120 immunogen.
Stephanie A Planque, Yukie Mitsuda, Vida Chitsazzadeh, Santhi Gorantla, Larisa Poluektova, Mary-Kate Morris

AIDS· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibodies to a superantigenic glycoprotein 120 epitope as the basis for developing an HIV vaccine.
Stephanie A Planque, Yukie Mitsuda, Yasuhiro Nishiyama, Sangeeta Karle, Stephane Boivin, Mary-Kate Morris

J Immunol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutralization of genetically diverse HIV-1 strains by IgA antibodies to the gp120-CD4-binding site from long-term survivors of HIV infection.
Stephanie Planque, Maria Salas, Yukie Mitsuda, Marcin Sienczyk, Miguel A Escobar, Mary-Kate Morris

AIDS· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis